Testosterone replacement drugs, those marketed for "Low T", have been shown to pose a two to three times higher risk of heart attack and stroke than normal. These drugs include:
More than 3 million prescriptions for testosterone replacement drugs were written in 2012, with total sales from these drugs exceeding $2 billion. The marketing of these drugs have received significant scrutiny in recent years for encouraging use without acknowledging the risks.
Testosterone attorneys are now investigating cases where a user of a testosterone therapy drug was taken and subsequently suffered a heart attack or stroke.